Prostate Cancer Screening: Evolution, Challenges, and Future Directions

Area of Science:

• Oncology
• Medical Diagnostics
• Public Health

Background:

• Prostate cancer screening has undergone significant evolution over the last 20 years.
• Traditional prostate-specific antigen (PSA) screening lowered mortality but caused overdiagnosis and overtreatment.
• Current approaches focus on identifying clinically significant disease and minimizing patient harm.

Purpose of the Study:

• To review the historical context and evolution of prostate cancer screening.
• To discuss the challenges associated with traditional screening methods.
• To highlight contemporary strategies and future directions for personalized prostate cancer screening.

Main Methods:

• Review of landmark trials and emerging evidence in prostate cancer screening.
• Integration of risk stratification, multiparametric MRI, biomarkers, and genomics.
• Analysis of historical data and current clinical practices.

Main Results:

• Traditional PSA screening reduced mortality but led to overdiagnosis.
• Contemporary strategies improve detection of clinically significant prostate cancer.
• Personalized screening approaches are supported by growing evidence.

Conclusions:

• Prostate cancer screening has advanced towards more personalized and precise methods.
• Innovations aim to enhance early detection of significant disease.
• Future directions focus on reducing unnecessary interventions and improving patient outcomes.